What is the CanAssist Breast test?

CanAssist Breast is a prognostic test that helps predict the risk of breast cancer recurrence and supports oncologists in personalizing treatment plans.

Who can benefit from the CanAssist Breast test?

It is suitable for patients diagnosed with early-stage, hormone receptor-positive breast cancer to determine their recurrence risk.

How accurate is the CanAssist Breast test?

CanAssist Breast has been validated on South Asian and Caucasian populations, demonstrating high accuracy in predicting recurrence risk.

Breast Cancer Recurrence, Early Stage 1, 2, Breast Cancer Test, India

Publication Type

Publication Year

59 Results Found.

Annals of Oncology

(Scientific Publication by OncoStem)

September, 2017

Risk of recurrence prediction and optimum treatment planning for early stage breast cancer patients: A cost-effective, accurate and broad based solution for Asia

View

Journal of Molecular Biomarkers & Diagnosis

(Scientific Publication by OncoStem)

January 2017

Assessment of Ki67 As a Prognostic Marker in Hormone Receptor Positive Breast Cancer: A Retrospective Study on An Indian Cohort

View

South Asian Journal of Cancer

(Scientific Publication by Renowned Oncologists Worldwide)

31 December, 2021

Purvish Parikh et al: Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive HER2 Negative Early Breast Cancer in India

View

+91 96866 96505

Scientific Publications

Subscribe
Newsletter

+91 96866 96505

Map
Location & Directions

+91 96866 96505

Scientific Publications

Subscribe Newsletter

+91 96866 96505

Map Location & Directions

Subscribe
Newsletter

Map
Location & Directions